Events and News
From emerging company to sponsor
Last year at this time, the KeraVet Bio team was hard at work on our Emerging Company Presentation after being chosen as one of ten “Emerging Company” presenters. This fall, we’re coming back as sponsors and will be eager to promote our recently launched product.
Veterinary biotech company gains local investment
The Winston-Salem Partners Roundtable Fund announced its investment in startup KeraVet Bio, bringing its total investment portfolio to seven early stage companies.
Raising capital and progress update
KeraVet Bio will soon close on its series seed 2 funding. We’ve been fortunate to have a lot of excitement around this new technology for the veterinary health market and have been able to make a lot of new connections because of it.
Clinical studies are underway
Our KeraVet Gel clinical study is underway and we’re anticipating results in March 2023. Our clinical study is taking place in South Africa and is being conducted by the scientists and veterinarians at ClinVet.
Send us a Message
